IDH1 and cholangiocarcinoma: The aim of the present work is to highlight the molecular differences in IDH1 mutated versus IDH1wt CCAs, with a special focus on the most relevant genomic alterations and their prognostic value in both CCA patients receiving a surgical intervention and those treated with systemic therapy.